Data mining and safety analysis of BTK inhibitors: A pharmacovigilance investigation based on the FAERS database

Objective: The introduction of Bruton’s tyrosine kinase (BTK) inhibitors was a milestone in the treatment of B-cell malignancies in recent years owing to its desired efficacy against chronic lymphocytic leukaemia and small cell lymphocytic lymphoma. However, safety issues have hindered its applicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Qing, Li, Qiang, Lai, Xin, Xu, Tiantian, Hu, Jinfang, Peng, Hongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691840/
https://www.ncbi.nlm.nih.gov/pubmed/36438789
http://dx.doi.org/10.3389/fphar.2022.995522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691840/
https://www.ncbi.nlm.nih.gov/pubmed/36438789
http://dx.doi.org/10.3389/fphar.2022.995522

Ejemplares similares